Mai, E. K., Bertsch, U., Egerer, G., Ho, A. D., Hillengaß, J., Raab, M., & Goldschmidt, H. (2016). Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: Long-term results from the phase III GMMG-HD2 trial. British journal of haematology, 173(5), . https://doi.org/10.1111/bjh.13994
Chicago-Zitierstil (17. Ausg.)Mai, Elias K., Uta Bertsch, Gerlinde Egerer, Anthony Dick Ho, Jens Hillengaß, Marc-Steffen Raab, und Hartmut Goldschmidt. "Single Versus Tandem High-dose Melphalan Followed by Autologous Blood Stem Cell Transplantation in Multiple Myeloma: Long-term Results from the Phase III GMMG-HD2 Trial." British Journal of Haematology 173, no. 5 (2016). https://doi.org/10.1111/bjh.13994.
MLA-Zitierstil (9. Ausg.)Mai, Elias K., et al. "Single Versus Tandem High-dose Melphalan Followed by Autologous Blood Stem Cell Transplantation in Multiple Myeloma: Long-term Results from the Phase III GMMG-HD2 Trial." British Journal of Haematology, vol. 173, no. 5, 2016, https://doi.org/10.1111/bjh.13994.